肿瘤分子靶向治疗的新观点

New perspectives on molecular targeted therapy for cancer

传统的细胞毒药物治疗肿瘤疗效已经达到了平台，单克隆抗体类靶向药物与化疗联合应用成为进一步提高疗效的关键。尽管靶向药物的特定性标靶人群尚未明确，但根据检测基因及蛋白状态、分子标准和临床标准选择合适的靶向药物已显示一定的应用前景。

The curative effect of traditional cytotoxic drugs in cancer treatment has reached a platform. Monoclonal antibody targeting drugs combined with chemotherapy become the key to improving efficacy. Though the specific target groups of targeted drugs has are still not clear, it might have a promising value in choosing suitable targeted drugs by testing the state of gene and protein, molecular and clinical criteria .